D.M. Davies

723 total citations
22 papers, 541 citations indexed

About

D.M. Davies is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, D.M. Davies has authored 22 papers receiving a total of 541 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cardiology and Cardiovascular Medicine, 4 papers in Surgery and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in D.M. Davies's work include Pharmaceutical Practices and Patient Outcomes (3 papers), Atrial Fibrillation Management and Outcomes (2 papers) and COVID-19 Clinical Research Studies (2 papers). D.M. Davies is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (3 papers), Atrial Fibrillation Management and Outcomes (2 papers) and COVID-19 Clinical Research Studies (2 papers). D.M. Davies collaborates with scholars based in United Kingdom. D.M. Davies's co-authors include M. D. Rawlins, Philip A. Routledge, P. H. Chapman, Alan MacIntyre, Madhav Menon, S. Lal, M. D. Rawlins, Nishant Sharma, PA Routledge and Roderick Walden and has published in prestigious journals such as The Lancet, Annals of Internal Medicine and Gut.

In The Last Decade

D.M. Davies

20 papers receiving 466 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D.M. Davies United Kingdom 9 102 93 86 82 70 22 541
Keith Beard United Kingdom 12 103 1.0× 45 0.5× 16 0.2× 54 0.7× 41 0.6× 16 364
Glen D. Park United States 16 180 1.8× 83 0.9× 317 3.7× 92 1.1× 136 1.9× 27 1.1k
Anthony R. Temple United States 17 83 0.8× 31 0.3× 277 3.2× 21 0.3× 90 1.3× 33 684
J. P. Kampmann Denmark 15 192 1.9× 16 0.2× 51 0.6× 118 1.4× 179 2.6× 27 1.1k
Suman Wason United States 22 105 1.0× 36 0.4× 290 3.4× 60 0.7× 124 1.8× 47 1.1k
Michael Tierney Canada 11 42 0.4× 27 0.3× 105 1.2× 27 0.3× 47 0.7× 22 535
Valeria Niro Italy 8 130 1.3× 74 0.8× 33 0.4× 94 1.1× 82 1.2× 11 650
Fred E. Karch United States 10 134 1.3× 352 3.8× 37 0.4× 52 0.6× 236 3.4× 34 900
O.F.W. James United Kingdom 19 67 0.7× 12 0.1× 77 0.9× 95 1.2× 91 1.3× 72 1.2k
Michael A. McGuigan Canada 14 78 0.8× 47 0.5× 274 3.2× 23 0.3× 89 1.3× 26 638

Countries citing papers authored by D.M. Davies

Since Specialization
Citations

This map shows the geographic impact of D.M. Davies's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.M. Davies with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.M. Davies more than expected).

Fields of papers citing papers by D.M. Davies

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D.M. Davies. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.M. Davies. The network helps show where D.M. Davies may publish in the future.

Co-authorship network of co-authors of D.M. Davies

This figure shows the co-authorship network connecting the top 25 collaborators of D.M. Davies. A scholar is included among the top collaborators of D.M. Davies based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D.M. Davies. D.M. Davies is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Davies, D.M.. (1988). Phaeochromocytoma and adverse drug reactions. Journal of Clinical Psychopharmacology. 8(1). 64–64. 4 indexed citations
2.
Sharma, Nishant, PA Routledge, M. D. Rawlins, & D.M. Davies. (1982). Predicting the Dose of Warfarin for Therapeutic Anticoagulation. Thrombosis and Haemostasis. 47(3). 230–231. 11 indexed citations
3.
Routledge, Philip A., P. H. Chapman, D.M. Davies, & M. D. Rawlins. (1979). Factors affecting warfarin requirements. European Journal of Clinical Pharmacology. 15(5). 319–322. 64 indexed citations
4.
Routledge, Philip A., et al.. (1978). Labetalol, a cross-over double blind controlled trial. European Journal of Clinical Pharmacology. 14(5). 301–304. 7 indexed citations
5.
Routledge, Philip A., et al.. (1977). Dose-titrated, double-blind, cross-over comparison of a selective beta-blocker and methyldopa in the treatment of hypertension. European Journal of Clinical Pharmacology. 11(3). 159–162. 3 indexed citations
6.
Routledge, PA, D.M. Davies, & M. D. Rawlins. (1977). Pharmacokinetics of tolamolol in the treatment of hypertension. European Journal of Clinical Pharmacology. 12(3). 171–174. 2 indexed citations
7.
Davies, D.M.. (1976). CLINICAL PHARMACOLOGY IN A DISTRICT GENERAL HOSPITAL. The Lancet. 307(7968). 1063–1065. 3 indexed citations
8.
Rawlins, M. D. & D.M. Davies. (1975). HOW DO DOCTORS LEARN ABOUT DRUGS?. The Lancet. 306(7946). 1201–1202. 6 indexed citations
9.
Davies, D.M.. (1972). PATIENT CARE AND HOSPITAL DOCTORS' OFF-DUTY TIME. The Lancet. 299(7747). 444–445. 1 indexed citations
10.
Tyrrell, Pippa, et al.. (1970). INTEGRATED SYSTEM FOR THE PURCHASE, DISTRIBUTION, AND USE OF DRUGS IN HOSPITAL. The Lancet. 295(7643). 408–410. 1 indexed citations
11.
S, Lal, et al.. (1970). Analgesics in myocardial infarction. American Heart Journal. 79(5). 717–718. 4 indexed citations
12.
Davies, D.M.. (1968). GLUCAGON IN SULPHONYLUREA HYPOGLYCÆMIA. The Lancet. 291(7552). 1154–1154. 1 indexed citations
13.
Davies, D.M., et al.. (1967). ACCIDENTAL HYPOTHERMIA TREATED BY EXTRACORPOREAL BLOOD-WARMING. The Lancet. 289(7498). 1036–1037. 62 indexed citations
14.
Davies, D.M., et al.. (1967). NEED FOR GLUCAGON IN SEVERE HYPOGLYCÆMIA INDUCED BY SULPHONYLUREA DRUGS. The Lancet. 289(7486). 363–364. 27 indexed citations
15.
Davies, D.M.. (1967). ACUTE PANCREATITIS AND FRUSEMIDE. The Lancet. 289(7504). 1386–1386.
16.
Davies, D.M., et al.. (1967). ACUTE PANCREATITIS ASSOCIATED WITH FRUSEMIDE THERAPY. The Lancet. 289(7481). 105–105. 30 indexed citations
17.
Davies, D.M., et al.. (1966). CHRONIC ETHCHLORVYNOL INTOXICATION. The Lancet. 288(7475). 1251–1252. 3 indexed citations
18.
Davies, D.M., et al.. (1963). AMITRIPTYLINE POISONING. The Lancet. 282(7307). 543–543. 18 indexed citations
19.
Davies, D.M., et al.. (1963). AMITRIPTYLINE POISONING. The Lancet. 282(7308). 643–643. 9 indexed citations
20.
Ritchie, H D, et al.. (1962). Extracorporeal methods of reducing high blood ammonia levels. Gut. 3(2). 172–176. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Keith Beard Breakdown of academic impact, for papers by Glen D. Park Breakdown of academic impact, for papers by Anthony R. Temple Breakdown of academic impact, for papers by J. P. Kampmann Breakdown of academic impact, for papers by Suman Wason Breakdown of academic impact, for papers by Michael Tierney Breakdown of academic impact, for papers by Valeria Niro Breakdown of academic impact, for papers by Fred E. Karch Breakdown of academic impact, for papers by O.F.W. James Breakdown of academic impact, for papers by Michael A. McGuigan
Rankless by CCL
2026